Informaciones Psiquiátricas - Segundo trimestre 2000. Número 160

Anexo II

Bibliografía

  • Alewijn, O., Monique, M., Breteler, M. B. & et al.: (1997) Atrial Fibrillation and dementia in a population based study: The Rotterdam Study. Stroke. 28 (2): 316-321.
  • Alexopoulos, G., Meyers, B. y Young, R. et al.: (1997) Vascular depression hypothesis. Archives of General Psychiatry, 54, 915-922
  • Alzheimer, A.: (1907) Uber eine eigenartige Erkrankung der Hirnrinde. Allgemeine zeitschrift fur psychiatrie und psychich-gerichtlich medizine 64, 146-148.
  • Amaducci, L. A., Fratiglioni, L. y Rocca, W. A. et al.: Risk factors for clinically diagnosed Alzheimer´s disease: A case-control study of an italian population. Neurology 1986; 36: 922-931.
  • American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington DC: AMA, 1994.
  • Armstrong, M., Daly, A. K., Cholerton, S., Bateman, D. N. y Idle J. R.: Mutant debrisoquine hydroxylation genes in Parkinson’s disease. Lancet 1992; 339: 1017-1018.
  • Bales, K. R., Verina, T. y Dodel, R. C. et al.: Lack of apolipoprotein E dramatically reduces amyloid beta-peptide deposition [letter] [see comments]. Nat. Genet. 1997; 17: 263-264.
  • Banerjee, S., Shamah, K. y MacDonald, A. et al.: (1988) The use of the selfcare(D) as a screening tool for depression in the clients of local authority home care services- A preliminary study. Int. J. Geriat Psychiatry. 13, 695-699.
  • Barret, A. M.: (1913) Presenile, artheriosclerotic and senile disorders of the brain and cord. In: The modern treatment of nervious and mental diseases. (Eds: White, W. A. y Jellife, S. A.) Kimpton, London, 675-709.
  • Basun, H., Corder, E. H. y Guo, Z. et al.: (1996) Apolipoprotein E polymorphism and stroke in a population sample aged 75 years or more. Stroke. 27 (8): 1310-1315.
  • Benjamin, R., Leake, A. y Edwardson J. A. et al.: Apolipoprotein E genes in Lewy body and Parkinsons disease. Lancet 1994; 343: 1565
  • Berrios, G. E.: (1996) The history of mental symptoms. 1st ed. Cambridge University Press, Cambridge. 565 pages.
  • Betard, C., Robitaille, Y. y Gee, M. et al.: APOE allele frequencies in Alzheimer’s disease, Lewy body dementia, Alzhiemers disease with cerebrovascular disease and vascular dementia. Neuroreport 1994; 5: 1893-1896.
  • Bird, A. S., Blizard, R. y Mann, A.: (1990) Treating hypertension in the older person: an evaluation of the association of blood pressure level and its reduction with cognitive performance. Journal of Hypertension. 8, 147-152.
  • Bird, A., MacDonald, A., Mann, A. H. y Philpot, M.: (1987) Preliminary experience with the Selfcare (D); A self-rating depression questionnaire for use in elderly, non-insititutionalized subjects. Int. J. Ger. Psych. 2. 31-38.
  • Blanchard, M., Waterreus, A. y Mann, A. H.: (1994) The nature of depression among older people in inne London and the contact with primary care. Br. J. Psychiatry 164: 396-402
  • Blanchard, M. R., Waterreus, A. y Mann A. H.: (1995) The effect of primary care nurse intervention upon older people screened as depressed. Int. Journ Geriatr Psychiatry, 10: 289-298
  • Blessed, G., Tomlinson, B. y Roth, M.: The association between qualitative measures of dementia and senile change in cerebral grey matter of elderly subjects. Br. J. Psychiatry 1968; 114: 797-811.
  • Bolla, K. I., Lindgren, K. N., Bonaccorsy, C. & Bleecker, M. L.: (1991) Memory complaints in the older adults. Fact of fiction?. Arch. Neurol. 48, 61-64
  • Boothby, H., Blizard, R., Livingston, G. y Mann, A. H.: The Gospel Oak Study stage III: The incidence of dementia. Psychological Medicine; 23
  • Boothby, H., Blizard, R. y Livingston, G. et al.: The Gospel Oak Study Stage III: The incidence of dementia. Psychological Medicine, 1993, 24, 89-95.
  • Brayne, C. & Calloway, P.: (1988) Normal ageing, impaired cognitive function, and senile dementia of the Alzheimer’s types: a continuum? Lancet i: 1265-1267.
  • Brenner, D. E., Kukull, W. A. y van Belle, G. et al.: Relationship between Alzheimer’s disease and cigarette smoking in a population-based case-control study. Neurology, 1993, 43: 293-300.
  • Broe, G. A., Akhtar, A. J., Andrews G. R., Caird, F. I., Gilmore, A. J. y McLennan, W. J.: Neurological disorders in the elderly at home. J. Neurol. Neurosurg Psychiatry 1976; 39: 361-366.
  • Broe, G. A., Creasey, H. y Jorm, A. F., et al.: (1998) Health habits and risk of cognitive impairment and dementia in old age: a prospective study on the effects of exercise, smoking and alcohol consumption. Australian & New Zealand Journal of Public Health. 22 (5): 621-623.
  • Bulbena, A. y Berrios, G. E.: (1986) Pseudodementia: facts and figures. Br. J. Psych. 148, 87-94.
  • Bulbena, A. y Cervilla, J. A.: (1997) Demencias. In: Introduccion a la psiquiatria y a la psicopatologia. 4th ed. (Ed: Vallejo, Ruiloba, J.) Masson, Barcelona, Spain.
  • Buntinx, F., Kester, A., Berrgers, J. y Knottnerus, J. A.: (1996) Is depression in elderly people followed by dementia? A retrospective cohort study based in general practice. Age and Ageing, 25, 231-233.
  • Carmelli, D., Swan, G. E. y Reed, T. et al.:The effect of Apolipoprotein E e4 in the relationships of smoking and drinking to cognitive function. Neuroepidemiology, 1999, 18 (3). 125-133.
  • Cervilla, J. A.: (2000d) Esquizofrenia. In: Fundamentos biológicos en psiquiatría. 1st ed. (Eds: Cervilla, J. A. y Garcia-Ribera, C.) Masson, Barcelona, 163-176.
  • Cervilla, J. A.: (2000e) Psiquiatría Orgánica I: Las Demencias. In: Fundamentos Biológicos en Psiquiatría. 1st ed. (Eds: Cervilla Ballesteros, J. A. y Garcia-Ribera, C.) Masson, Barcelona, pp 101-116.
  • Cervilla, J. A., Prince, M. y Mann, A.: (1997) The epidemiology of Alzheimer’s disease. In: Advances in Old Age Psychiatry: From chromosomes to community care. (Eds: Holmes, C. y Howard, R.) Wrightson biomedical publishing , Petersfield, UK, 3-22.
  • Chandra, V., Ganguli, M., Pandav, R., Johnston, J., Belle, S. y DeKosky S. T: Prevalence of Alzheimer’s disease and other dementias in rural India. The Indo-US study. Neurology 1998; 51: 1000-1008.
  • Chandra, V. y Pandav, R.: Gene-Environment Interaction in Alzheimer’s Disease: A Potential Role for Cholesterol. Neuroepidemiology 1998; 17: 225-232. (Abstract)
  • Chen, X., Xia, Y. y Alford, M. et al.: The CYP2D6B allele is associated with a milder synaptic pathology in Alzheimer’s disease. Annals of Neurology 1995; 38: 653-658.
  • Clouston,T. S.: (1887) Clinical lectures on mental disease. 2nd ed. Churchill, London.
  • Copeland, J. R. M., Dewey, M. E. & Griffith-Jones, H. M.: (1986) A computerised psychiatric diagnostic system and case nomenclature for elderly subjects: GMS and AGECAT. Psychological medicine 16, 89-99.
  • Copeland, J. R., Dewey, M. E., Wood, N., Searle, R., Davidson, I. A. & McWillian, C.: (1987) Range of mental illness among the elderly in the community. Prevalence in Liverpool using the GMS-AGECAT package. Br. J. Psychiatry 150, 815-823.
  • Corder, E. H., Saunders, A. M. y Strittmatter, W. J. et al.: (1993) Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer’s disease in late onset families. Science, 1993, 261: 921-923.
  • Crook, T., Bahar, H. & Sudilovsky, A.: (1987) Age-associated memory impairment: diagnostic criteria and treatment strategies. Int. J. Neurol. 21-22, 73-82.
  • Cullen, M. C., Blizzard, R., Livingston, G. y Mann, A.: The Gospel Oak Project 1987-1990: Provision and use of community services. Health Trends 1993, 25: 142-146
  • Cullen, W.: (1827) The works of William Cullen. Edited by John Thompson ed. Vol. 2. William Blackwood, Edimburgh.
  • Cummings, J. L., Ross, W. y Absher, J. et al.: (1995) Depressive symptoms in Alzheimer’s disease. Alzheimer’s disease and associated disorders. 9. 87-93.
  • Davignon, J., Gregg, R. E. y Sing, C. F.: Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis 1988; 8: 1-21.
  • Devanand, D. P., Sano, M. y Tang, M. et al.: (1996) Depressed mood and the incedence of Alzheimer’s disease in the elderly living in the community. Archives of General Psychiatry. 53, 175-182.
  • Diderot y D’Alembert: (Eds.) (1753-1765) Encyclopedie ou Dictionnaire Raisonne des Sciences, des Artes, et des Meiters, par una Societe de Gens de lettres. Briasson, David, Le Breton, Durand, Paris.
  • Duffy, J. D. y Coffey, C. E.: (1995) Secondary mood disorders in patient with neurological disease. Current Opinion in Psychiatry, 8, 61-63
  • Dufouil, C., Fuhrer, R. y Dartigues, J.F. et al.: (1996) Longitudinal analysis of the association between depressive sympomatology and cognitive deterioration. American Journal of Epidemiology. 144, 7, 634-641.
  • Dufouil, C., Ducimetiere, P., & Alperovitch, A.: (1997) Sex differences in the association between alcohol consumption and cognitive performance. American Journal of Epidemiology. 146 (5) 405-412.
  • Edelstein, S., Krits-Silverstein, D. y Barret-Connor, E. et al.: Prospective association of smoking and alcohol use with cognitive function in and elderly cohort. Journals of Women-s Health 1998, 7 (10) , 1271-1281.
  • Egensperger, R., Bancher, C., Kosel, S., Jellinger, K., Mehraein, P. y Graeber, M. B.: The Apolipoprotein e4 allele in Parkinsons disease with Alzheimer dementia lesions. Biochem Biophys Res Commun 1996; 224: 484-486.
  • Eichelbaum, M.: Genetic polymorphisms of sparteine’debisoqurine oxidation. 1988; 243-251.: (Abstract)
  • Elias, M. F., Wolf, P. A. y D’Agostino, R. B. et al.: (1993) Untreated blood pressure level is inversely related to cognitive functioning: the Framingham Study. American Journal of Epidemiology. 138 (6): 353-364.
  • Elwood, P. C., Gallacher, J. E. y Hopkinson, C. et al.: Smoking, drinking and other lifestyle factors and cognitive function in men in the Caerphilly cohort. Journal of Epidemiology and community health. 1999, 53 (1) 9-14.
  • Farmer, M. E., Kittner, S. J. y Abbott, R. D., et al.: (1990) Longitudinally measured blood pressure, antihypertensive medication use, and cognitive performance: the Framingham Study. J. Clin. Epidemiol. 43:475-480.
  • Feskens, E. J., Havekes, L. M. y Kalmijn, S. et al.: (1994) Apolipoprotein e4 allele and cognitive decline in elderly men. 309: 1202-1206.
  • Folstein, M. F., Folstein, S. E. y McHugh, P. R. «Mini-mental State»: A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research 1975; 12: 189-198.
  • Ford, D. E. & Kamerow, D. B.: (1989) Epidemiologic study of sleep disturbances and psychiatric disorders. An opportunity for prevention?. JAMA 262, 1479-1484
  • Forno, L. S. y Langston, J. W.: Lewy bodies and ageing: Relation to Alzheimers and Parkinsons disease. Neurodegen 1993; 2: 19-24.
  • Fourrier, A., Letenneur, L. y Begaud, B. et al.: (1996) Nonsteroidal antiinflammatory drug use and cognitive function in the elderly: inconclusive results from a population-based cohort study. Journal of Clinical Epidemiology. 49 (10): 1201.
  • Fuhrer, R., Antonucci, T. C. y Gagnon, M. et al.: (1992) Depressive synptomatology and cognitive functioning: an epidemiological survey in an elderly community sample in France. Psychological Medicine. 22, 159-172.
  • Galanis, D. J., Petrovitch, H. y Launer, L. J. et al.: Smoking history in middle age and subsequent cognitive performance in elderly japanase-american men: The Honolulu- Asia Aging study. American Journal of Epidemiology. 1997. vol 145 (6), 507-515.
  • Galasko, D., Saitoh, T. y Xia, Y. et al.: The Apolipoprotein E allele 4 is overrepresented in patients with the Lewy body variant of Alzheimers disease. Neurology 1996; 44: 1950-1951.
  • Gearing, M., Schneider, J. A., Rebeck G.W., Hyman, B. T. y Mirra, S. S.: Alzheimers disease with and without coexistin Parkinsons disease changes: Apolipoprotein E genotype and neuropathologic correlates. Neurology 1995; 45: 1985-1990.
  • Georget, E. J.: (1820) De la Folie. Considerations sur cette la maladie. Crevot, Paris.
  • Gill, C., Richardson, E., & Tinetti, M.: (1995) Evaluating the risk of dependence in activities of daily living among community/living older adults with mild cognitive impairment. J. Gerontol. A. Biol. Sci. MEd. Sci. 50: 235-241.
  • Golden, R. R., Teresi, J. A. & Gurland, B. J.: (1984) Development of indicator scales for the comprehensive assessment for referral evaluation (CARE) interview schedule. Journal of Gerontoloy 39, 138-146.
  • Graves, A. B., White, E. y Koepsell, T. et al.: A case-control study of Alzheimer’s disease. Ann. Neurol. 1990; 28: 1698-1707.
  • Graves, A. B., van Duijn, C. M. y Chandra, V. et al.: Alcohol and tobacco consumption as risk factors for Alzheimer’s disease: A collaborative re-analysis of case-control studies. International Journal of Epidemiology. 1991. 20, 2 (suppl.2), s48- s57.
  • Griesinger, W.: (1861) Die pathologie und Therapie der psychischen Krankheiten. 2nd ed. Krabbe, Stuttgart.
  • Griffiths, R. A., Good, W. R., Watson, N. P., O’Donell, H. F., Fell, P. J. & Shakespeare, J. M.: (1987) Depression, dementia and disability in the elderly. Br. J. Psychiatry 150, 482-493
  • Guillaume, D., Bertrand, P. y Dea, D.: (1996) Apolipoprotein E and LDL binding internalization in primary cultures of rat astrocytes: isoform especific alterations. J. Neurochem. 1996. 66, 2410-2418.
  • Gurland, B., Golden, R. R., Teresi, J. A. & Challop, J.: (1984) Athe Short-CARE: An efficient instrument fot the assessment of depression, dementia and disability. Journa of Gerontology, 39, 166-169.
  • Gurland, B., Golden, R. R. y Teresi, J. A. et al.: The Short CARE: An efficient instrument for the assessment of depression, dementia and disability. Journal of Gerontology, 39, 166-169.
  • Gurland, B. J., Copeland, J., Kuriansky, J., Kelleher, M., Sharpe, L. y Dean, L.: (1983) The mind and mood of aging. London: Croom Helm.
  • Gurland, B., Kuriansky, J. y Sharpe, L., et al.: (1977) The comprehensive assessment of referral evaluation (CARE)- rationale, development and reliability. Int. J. Ageing Hum Devel. 8, 9-42.
  • Handelmann, G. E., Boyles, J. K., Weisgraber, K. H., Mahley, R. W. y Pitas, R. E.: Effects of apolipoprotein E, beta-very low density lipoproteins, and cholesterol on the extension of neurites by rabbit dorsal root ganglion neurons in vitro. J. Lipid. Res. 1992; 33: 1677-1688.
  • Hansen, L., Salmon, D. y Galasko, D.: The Lewy body variant of Alzheimer’s disease: a clinical and pathologic entity. Neurology 1990; 40: 1-8.
  • Hansen, L. y Galasko, D.: Lewy body disease. Curr Opin Neurol,Neurosurg 1992; 5: 889-894.
  • Harwood, R. H. y Ebrahim, S.: Manual of the London Handicap Scale. University of Nottingham, 1995, Nottingham.
  • Hebert, L. E., Scherr, P. A. y Beckett, L. A. et al.: Age specific incidence of Alzheimer’s disease in a community population. JAMA 1995, 273: 1354-1359.
  • Hedera, P., Lerner, A. J., Catellani, R. y Friedland, R. P.: Concurrence of Alzheimers disease, Parkinsons disease, diffuse Lewy body disease and amyotrophic lateral sclerosis. J. Neuro. Sci. 1995; 128: 219-224.
  • Henderson, A. S., Korten, A. E. y Jacob, P. A. et al.: (1997) The course of depression in the elderly: a longitudinal community-based study in Australia. Psychological Medicine. 27, 119-129.
  • Hendrie, H. C., Gao, S. y Hall, K. S. et al.: (1996) The relationship between alcohol consumption, cognitive performance, and daily functioning in an urban sample of older black Americans. Journal of the American Geriatrics Society. 44 (10): 1158-1165.
  • Hoffbauer, J. C.: (1827) Medicine legale relative aux alienes et aux souds-muets ou les lois appliquees aux desordres de l’intelligence. 1st. ed. Baillere, Paris.
  • Hofman, A., Ott, A. y Breteler, M. B. et al.: Atherosclerosis, apolipoprotein E and the prevalence of dementia and Alzheimer´s disease in the Rotterdam Study. Lancet 1997, 349, 151-154.
  • Hofman, A., Rocca, W. A. y Brayne C, et al.: The prevalence of dementia in Europe: a collaborative study of 1980-1990 findings. Eurodem Prevalence Research Group. Int J. Epidemiol 1991;20:736-748.
  • Holmes C.: The Camberwell Dementia Case Register. Int. Journ of Geriat Psych 1996; 12: 369-376.
  • Inglis, J.: (1959) A Paired-Associate Learning Test for use with elderly psychiatric patients. Journal of Mental Science. 105: 440-443.
  • International Journal of Geriatric Psychiatry: (1990) The prevalence of depression in old age (editorial). International Journal of Geriatric Psychiatry 5, 141-144
  • Jarvik, G. P., Wijsman, E. M., Kukull, W. A., Schellenberg, G. D., Yu, C. y Larson EB.: Interactions of apolipoprotein E genotype, total cholesterol level, age, and sex in prediction of Alzheimer’s disease. Neurology 1995; 45: 1092-1096.
  • Jorm, A. F., van Duijn, C. y Chandra, V. et al.: (1991) Psychiatric History and related exposures as risk factors for Alzheimer’s disease: A collaborative re-analysis of case-control studies. International Journal of Epidemiology. 20, 2, suppl. 2, s43-s47.
  • Kalmijn, S., Launer, L. J., Ott, A., Witteman, J. C., Hofman, A. y Breteler, M. M.: Dietary fat intake and the risk of incident dementia in the Rotterdam Study. Ann. Neurol. 1997; 42: 776-782.
  • Kalmijn, S., Feskens, E. y L. Launer, et.: (1997) Longitudinal study of the effect of apolipoprotein e4 alleles on the association between education and cognitive decline in elderly men. British Medical Journal. 314: 34-35.
  • Katzman, R., Aronson, M. y Fuld, et al.: (1989) Development of dementing illnesses in an 80-year-old volunteer cohort. Ann. Neurol. 25: 317-324.
  • Kay, D. W. K., Henderson, A. S. y Scott, R. et al.: (1985) Dementia and depression among the elderly living in the Hobart community: the effect of the diagnostic criteria on the prevalence rates. Psychological Medicine. 15, 771-788.
  • Kilander, L., Nyman, H. y Boberg, M. et al.: (1998) Hypertension is related to cognitive impairment: a 20-year follow-up of 999 men. Hypertension. 31 (3): 780-786.
  • Kiloh, L. G.: (1961) Pseudodementia. Acta Psiquiatrica Scandinavica, 37, 336-351.
  • Kim, D. H., Iijima, H. y Goto, K. et al.: (1996) Human apolipoprotein E receptor 2. A novel lipoprotein receptor of the LDL receptor family predominantly expressed in brain. J. Biol. Chem., 271: 8373-8380.
  • Kokmen, E., Chandra, V. & Schoenberg, B. S.: (1988) Trends in incidence of dementing illness in Rochester, Minnesota, in three quinquennial periods, 1960-1974. Neurology 38: 975-980
  • Kraepelin, E.: (1906) Lectures on clinical psychiatry. 2nd ed. Tindall and Cox, London.
  • Krafft-Ebing, R.: (1876) De la demence senile. Annales medico-psychologiques 34, 306-7.
  • Krishnan, K., Ranga, R. y Hays, J. Ä. et al.: (1997) MRI defined vascular depression. American Journal of Psychiatry. 154 (4), 497-501.
  • Kukull, W. A.: Problems in measuring and interpreting cognitive decline [editorial]. Journal of the American Geriatrics Society. 1998, 46 (12): 1578-1579.
  • Kuller, L. H., Shemanski, L. y Manolio, T. et al.: (1998) Relationship between ApoE, MRI findings, and cognitive function in the Cardiovascular Health Study. Stroke. 29 (2): 388-398.
  • Kurz, A. et al.: (1996) APOE e4 allele, cognitive decline and deterioration of everyday performance in Alzheimer’s disease. Neurology, 47: 440-443.
  • Launer, L. J., Feskens, E. J. M. y Kalmijn, S. et al.: (1996) Smoking, drinking, and thinking. The Zutphen elderly study. American Journal of Epidemiology. 143(3): 219-227.
  • Launer L. J., Andersen, K. y Dewey, M. E. et al.: Rates and risks factors for dementia and Alzheimer’s disease: Results from the EURODEM pooled analyses. Neurology, 1999, 52, 78-84.
  • Launer, L. J., Masaki, K. y Petrovitch, H. et al.: (1995) The association between midlife blood pressure levels and late life cognitive function. The Honolulu/Asia Aging Study. 247 (23): 1846-1851.
  • Levin, E. D.: Nicotinic systems and cognitive function. Psychopharmacology. 1992, 108: 417-31
  • Liu, I. Y., Lacroix, A. Z. & White, L.: Cognitive Impairmente and mortality: A study of possible confounders. American Journal of Epidemiology. 1990 132: 136-143.
  • Liu, I. Y. et al.: (1990) Cognitive Impairment and mortality: A study of possible confounders. Am. J. Epid. 132, 136-143.
  • Livingston, G., Hawkins, A., Graham, N., Blizard, B. y Mann, A.: (1990) The Gospel Oak study: Prevalence rates of dementia, depression and activity limitation among the elderly residents in inner London. Psychological Medicine 1990, 20: 137-146.
  • Livingston, G., Thomas, A., Graham, N., Blizard, B. y Mann, A.: (1990) The Gospel Oak Priject: The use of health and social services by dependent elderly people in the community. Health Trends 1990; 2: 70-73.
  • Livingston, G., Saz, K., Willison, J., Blizard, B. y Mann, A.: The Gospel Oak Study stage II: The diagnosis of dementia in the community. Psychological Medicine 1990; 20: 146-156.
  • Livingston, G., Blizard, B & Mann, A. H.: (1993) Does sleep disturbance predict depression in elderly people? A study in inner London. Br. J. Gen. Pract. 42: 445-448.
  • Livingston, G., Sax, B., McClenahan, Z., Blementhal, E., Foley, K., Willison, J., Mann, A. y James, I.: (1991) Acetyl-l- carnitine in dementia. International journal of geriatric psychiatry. 6: 853-860.
  • Livingston, G., Sax, K. y Willison, J. et al.: The Gospel Oak study stage II: the diagnosis of dementia in the community. Psychological Medicine, 1990, 20, 881-891.
  • Lobo, A., Saz, P. y Marcos, G. et al.: (1995) The prevalence of dementia and depression in the elderly community in a Southern European population. Archives of General Psychiatry. 52, 497-506.
  • Mahgoub, A., Idle, J. R., Dring, L. G., Lancester, R., y Smith, R. L.: Polymorphic hydroxilation of debrisoquine in man. Lancet 1977; 1977: 718.
  • Mahley R. W.: (1998) Apolipoprotein E: Cholesterol transport protein with an expanding role in cell biology. Science, 240, 622-630.
  • Kay, D. W. K., Beamish, P. & Roth, M.: (1964) Old age mental disorders in Newcastle upon Tyne. Part 1: A study of prevalence. British Journal of Psychiatry, 11, 146-178.
  • Maudsley, H.: (1895) The pathology of mind. Mac Millan and Company, London.
  • Mayeux, R., Saunders, A. M. y Shea, S. et al.: Utility of the apolipoprotein E genotype in the diagnosis of Alzheimer’s disease. Alzheimer’s Disease Centers Consortium on Apolipoprotein E and Alzheimer’s Disease. N. Engl. J. Med. 1998; 338: 506-511.
  • McKeith, I. G., Perry, R. H., Fairbairn, A. F., Jabeen, S. y Perry, E. K.: Operational criteria for senile dementia of Lewy body type (SDLT). Psychol. Med. 1992; 22: 911-922.
  • McKhan, G., Drachman, D., Folstein, M. F., Katzman, R., Price, D. y Stadian, E. M.: Clinical diagnosis of Alzhemimer disease: report of the NINCDS-ADRDA work group. Neurology 1984; 34: 939-944.
  • Merchant, C., Tang, M. X., Albert, S., Manly, J., Stern, Y. y Mayeux, R.: The influence of smoking on the risk of Alzheimer’s disease. Neurology 1999. 52(7): 1408-12.
  • Morel, B. A.: (1860) Traite de Maladies Mentales. Masson, Paris.
  • Mouchel, Y., Lefrancois, T. y Fages, C. et al.: Apolipoprotein E gene expression in astrocytes: developmental patern and regulation. NeuroReport 1995, 7, 205-208.
  • MRC Working Party: MRC Research Council Trial of treatment of hypertension in older adults: principal results. British Medical Journal 1992; 304: 405-412.
  • Nalbantoglu, J., Gilfix, B. M. y Bertrand, P. et al.: Predictive value of apolipoprotein E genotyping in Alzheimer’s disease: results of an autopsy series and an analysis of several combined studies. Ann. Neuro.l 1994; 36: 889-895.
  • Nelson, H. & O’Connell, A.: (1978) Dementia. The estimation of pre-morbid intelligence levels using the New Adult Reading Test. Cortex. 14: 234-244.
  • O’Brien, J. T., Ames, D. y Schweitzer, I. et al.: (1996) Clinical and magnetic resonance imaging correlates of hypothalamic-pituitary-adrenal axis function in depression and Alzheimer’s disease. Brit. Journ Psych. 168, 679-687.
  • O’Brien, J. T. & Levy, R.: (1992) Age associated memory impairment (editorial) (see comments). BMJ. 304, 5-6
  • Orrell, M. y Bebbington, P.: (1995) Social factors and psychiatric admission for senile dementia. Int. J. Geriat. Psych. 10: 313-323
  • Ott, A., Breteler, M. M., de Bruyne, M. C., van Harskamp, F., Grobbee D. E. y Hofman, A.: Atrial fibrillation and dementia in a population-based study. The Rotterdam Study. Stroke 1997; 28: 316-321.
  • Ott, A., Slooter, A. J. C. y Hofman, A. et al.: Smoking and risk of dementia and Alzheimer’s disease in a population-based cohort study: the Rotterdam Study. Lancet 1998; 351: 1841-1843.
  • Pinel, P. H.: (1798) Nosographie Philosophique ou la methode. 6th (1818) ed. Vol. 1. Brosson, Paris.
  • Pitas, R. E., Boyles, J. K. y Lee, S. H. et al.: (1987) Lipoproteins and their receptors in the central nervous system. Characterization of the lipoproteins in cerebrospinal fluid and identification of apolipoprotein B,E (LDL) receptors in the brain. J. Biol. Chem. 1987, 262, 14352-14360.
  • Plasman, B. et al.: (1996) APOE and cognitive decline in Alzheimer’s disease. Neurology, 47: 317-320.
  • Price-Evans, D. A., Mahgoub, A., Sloan, T. P., Idle, J. R. y Smith, R. L.: A family and population study of the genetic polymorphism of debrisoquine oxidation in a white British population. J. Med. Genet. 1980; 17: 102-105.
  • Prichard, J. C.: (1835) Treatise on Insanity and other disorders affecting the mind. Sherwood, London.
  • Prince, M. J., Harwood, R., Thomas, A. y Mann, A. H.: (1996) Gospel Oak V: Impairment, disability and handicap as risk factors for depression in old age. Psychological Medicine 1996 (in press)
  • Prince, M. J., Harwood, R., Thomas A. y Mann, A. H.: (1996) Gospel Oak VI: Social support deficits, lonelyness, and life events as risk factors for depression in old age. Psychological Medicine 1996 (in press)
  • Prince, M., Harwood, R. y Thomas, A. et al.: A prospective population-based cohort study of the effects of disablement and social milieu on the onset and maintenance of late-life depression. The Gospel Oak Project VII. Psychological Medicine, 1998, 28, 337-350.
  • Prince, M. J., Lewis, G. y Bird, A. et al.: (1996) A longitudinal Study of factors predicting change in cognitive test scores over time, in an older hypertensive population. Psychological Medicine. 26, 555-568.
  • Prince, M. J.: (1995) Vascular risk factors and atherosclerosis as risk factors for cognitive decline and dementia. Journal of Psychosomatic Research 39, 5, 525-530.
  • Prince, M. J., Bird, A. S. y Blizard, R. A. et al.: (1996b) Is the cognitive function of older patients affected by antihypertensive treatment? Results from 54 months of the Medical Research Council’s treatment trial of hypertension in older adults. British Medical Journal. 312: 801-805.
  • Prince, M., Rabe-Hesketh, S. & Brennan, P.: (1998) Do antiarthritic drugs decrease the risk for cognitive decline? An analysis based on data from the MRC treatment trial of hypertension in older adults. Neurology. 50 (2): 374-379.
  • Prince, M. J., Cullen, M. C., & Mann, A. H. (1994). Risk factors for Alzheimer’s disease and dementia: A case-control study based on the MRC Elderly Hypertension Trial. Neurology 44: 97-104.
  • Prince, M. J.: Vascular risk factors and artherosclerosis as risk factors for cognitive decline and dementia. Journal of Psychosomatic Research, 1995, vol 39, 5, 525-530.
  • Prince, M. J., Harwood, R. H. y Blizard, R. A. et al.: Impairment, disability and handicap as risk factors for depression in old age. The Gospel Oak Project V. Psychological Medicine, 1997, 27 (2), 311-321.
  • Raven, J. C.: (1940) Matrix Tests. Mental Health. 1: 10-18.
  • Reltan, R. M.: (1959) Validity of the Trail Making Test as an indication of organic brain damage. Perceptual Motor Skills. 8: 271-276.
  • Riggs, J. E.: Smoking and Alzheimer’s disease: protective effect or differential survival bias? The Lancet. 1993: 342: 793-794.
  • Roman, G. C., Tatemichi, T. K. y Erkinjuntti, T. et al.: Vascular dementia: Diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 1993; 43: 250-260.
  • Rorsman, B., Hagnell, O. y Lanke, J.: (1986) Prevalence and incidence of senile and multi-infarct dementia in the Lundby study: a comparison between the time periods 1947-1957 and 1957-1972. Neuropsychobiology 15, 122-129.
  • Roses, A. D., Einstein, G. y Gilbert, J. et al.: Morphological, biochemical, and genetic support for an apolipoprotein E effect on microtubular metabolism. Ann. N. Y. Acad. Sci. 1996; 777: 146-157.
  • Roth, M., Tym, E. y Mountjoy, C. Q. et al.: CAMDEX. A standardised instrument for the diagnosis of mental disorder in the elderly with special reference to the early detection of dementia. British Journal of Psychiatry 1986; 149: 698-709.
  • Saag, K. G., Rubenstein, L. M. y Chrischilles, E. A. et al.: (1995) Nonsteroidal antiinflammatory drugs and cognitive decline in the elderly. Journal of Rheumatology. 22 (11): 2142-2147.
  • Saitoh, T., Xia, Y. y Chen. X. et al.: The CYP2D6B mutant allele is overrepresented in the Lewy body variant of Alzheimer’s disease. Annals of Neurology 1995; 37: 110-112.
  • Sapolsky, R. M., Krey, L. C. y McEwen, B.: (1986) The neuroendocrinology of stress and aging: the glucocorticoid cascade hypothesis. Endocr. Rev. 7: 284-301.
  • Saunders, A. M., Strittmatter, W. J. y Schmechel, D. et al.: Association of apolipoprotein E allele e4 with late-onset familial and sporadic Alzheimer’s disease. Neurology 1993; 43: 1467-1472.
  • Schmand, B. y Smit.: (1997) The effects of intelligence and education on the development of dementia: A test of the brain reserve hypothesis. Psychological Medicine. 27 (6): 2490-2494.
  • Shalat, A. L., Seltzer, B. y Pidcock, C. et al.: Risk factors for Alzheimer’s disease. Neurology 1987; 37: 1295-1300.
  • Shinton, R. y Beevers, G.: Metanalysis of the relation between cigarette smoking and stroke. Br. Med. J. 1989, 298, 789-94
  • Sing, C. F. y Davignon, J.: Role of the apolipoprotein E polymorphism in determining normal plasma lipid and lipoprotein variation. Am. J. Hum. Genet. 1985; 37: 268-285.
  • Skoog, I., Lernfelt, B. y Landahl, S. et al.: 15-year longitudinal study of blood pressure and dementia. The Lancet 1996; 347: 1141-1145.
  • Small, B. J.: (1998) Three-year changes in cognitive performance as a function of apolipoprotein E genotype: Evidence from very old adults without dementia. Psychology & Aging. 13 (1): 80-87
  • Smits, C. et al.: Social participation and cognitive function in older adults. Int. J. Geriat Psych. 10, 325-331
  • Smith, G. E., Bohac, D. L. y Waring, et al.: (1998) Apolipoprotein E genotype influences cognitive ‘phenotype’ in patients with Alzheimer’s disease but not in healthy control subjects. Neurology. 50 (2): 355-362.
  • Smith, C. A., Gough, A. C. y Leigh P. N. et al.: Debrisoquine hydroxylase gene polymorphism and susceptibility to Parkinson’s disease [published erratum appears in Lancet 1992 Jul. 4; 340 (8810): 64. Lancet 1992; 339: 1375-1377.
  • Sobrino: (1791) Aumentado o nuevo diccionario de las lenguas espanola, francesa y latina. 1st ed. JB Delamolliere, León de Francia.
  • Sparks, D. L.: Coronary artery disease, hypertension, ApoE, and cholesterol: a link to Alzheimer’s disease? Ann N. Y. Acad. Sci. 1997; 826: 128-146.
  • Speck, C. E., Kukull, W. A. y Brenner, D. E. et al.: (1995) History of depression as a risk factor for Alzheimer’s disease. Epidemiology. 6: 366-369.
  • St Clair, D., Norrman, J., Perry, R., Yates, C., Wilcock, G. y Brookes, A.: Apolipoprotein E 4 allele frequency in patients with Lewy body dementia, Alzheimer’s disease and age-matched controls. Neurosci Lett 1994; 176: 45-46.
  • Stewart, R.: (1999) Hypertension and cognitive decline. British Journal of Psychiatry. 174: 286-287.
  • Streit, W. J. y Sparks, D. L.: Activation of microglia in the brains of humans with heart disease and hypercholesterolemic rabbits. J. Mol. Med. 1997; 75: 130-138.
  • Strittmatter, W. J., Weisgraber, K. H. y Huang, D. Y. et al.: Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease. Proc. Natl. Acad. Sci. U.S.A 1993; 90: 8098-8102.
  • Strittmatter, W. J., Saunders, A. M. y Goedert, M. et al.: Isoform-specific interactions of apolipoprotein E with microtubule-associated protein tau: implications for Alzheimer disease. Proc. Natl. Acad. Sci. U.S.A. 1994; 91: 11183-11186.
  • Strittmatter, W. J., Weisgraver, K. H. y Huang, D. Y. et al.: (1993) Binding of human apolipoproten E to synthetic amyloid beta peptide: isoform-specific effects and implications for late onset Alzheimer´s disease. Proc. Natl. Acad. Sci. U.S.A. 90, 8098-8102.
  • Strong, C., Anderton, B. H., Perry, R. H., Perry, E. K., Ince, P. G. y Lovestone, S.: Abnormally pshosphorilated Tau protein in senile dementia of Lewy body type and Alzheimer disease: evidence that the disorders are distinct. Alz. Dis. societ relat dis. 1995; 9: 218-222.
  • Sullivan, G. F., Copeland, J. R. H., Dewey, M. E. & Davidson, A.: (1988) Benzodiazepiene usage among the elderly. International Journal of Geriatric Psychiatry 3: 289-292.
  • Swaab, D. F.: (1991) Brain ageing and Alzheimer’s disease, «wear and tear» versus «use it or loose it». Neurobiology of Aging. 12: 317-324.
  • Takahashi, S. et al.: (1992) Rabbit very low density lipoprotein receptor: A low density lipoprotein receptor like protein with distinc ligand specificity. Proc. Natl. Acad. Sci. U.S.A. 1992, 89, 9252-9256.
  • Teresi, J. A., Golden, R. R. y Gurland, B. J. et al.: Construct validity of indicator scales developed from the Comprehensive Assessment and Referral Evaluation Interview Schedule. Journal of Gerontology, 1984, 39, 147-157.
  • Teri, L., Hughes, J. P. y Larson, E. B.: Cognitive deterioration in Alzheimer’s disease: behavioural and health factors. J. Gerontol 1990, 42, 3-10.
  • The international classification of diseases 10th edition. Chapter V: Mental and Behavioural disorders. World Health Organisation. London. Churchill Livingstone, 1994.
  • Tobiansky, R., Blizard, R., Livingston, G. y Mann, A.: The Gospel Oak study stage IV: the clinical relevance of subjective memory impairment in older people. Psychol Med. 25: 779-786
  • Uusitupa, M., Sarkkinen, E., Kervinen, K. y Kesaniemi, Y. A.: Apolipoprotein E phenotype and blood pressure. The Lancet 1994; 343: 57.
  • Van Belle, G., Uhlmann, R. y Hughes, J. P. et al.: (1990) Reliability of estimates of changes in mental status test performance in senile dementia of the Alzheimer’s type. J. Clin. Epidemiol. 43: 589-595.
  • Van Duijn, C. M. y Hofman, A.: Relation between nicotine intake and Alzheimer’s disease. BMJ; 302: 1491-94
  • Van Duijn, R., Stijner, T. y Hoffman, A.: Risk factors for Alzheimers disease: An overview of the EURODEM collaborative re/analysis of case/control studies. I. J. Epidemiology 1996; 20 (Suppl.): s4-s12.
  • Van Duijn, C. M., Havekes, L. M., Van Broeckhoven, C., de Knijff, P. y Hofman, A.: Apolipoprotein E genotype and association between smoking and early onset Alzheimer’s disease. BMJ 1995; 310: 627-631.
  • Walker: (1968) Crime and insanity in England, Historical perspective. Vol. 1. Edimburgh University Press, Edimburgh.
  • Webster, D. D.: Critical analysis of the disability in Parkinsons disease. Mod. Treat 1968; 5: 257-287.
  • Weich, S.: (1998) The Cohort Study. In Research Methods in Psychiatric Epidemiology. Int. Rev. Psychiatry. 10, 4: 284-290.
  • Weiler, P. G., Lubben, J. E. & Chi, I.: (1991). Cognitive impairment and hospital use. Am. J. Public Health. 81: 1153-1157.
  • Wenham, P. R., Price, W. H. y Blandell, G.: Apolipoprotein E genotyping by one-stage PCR. Lancet 1991; 337: 1158-1159.
  • Weverling, Rijnsburger, A. W., Blauw, G. J., Lagaay, A. M., Knook, D. L., Meinders, A. E. y Westendorp, R. G.: Total cholesterol and risk of mortality in the oldest old. Lancet 1997; 350: 1119-1123.
  • Whittington, J. E. y Huppert, F. A.: Smoking and cognitive decline. Human psychopharmacology. 1997. vol 12 (5), 467-480.
  • Wilson, P. W., Myers, R. H., Larson, M. G., Ordovas, J. M., Wolf, P. A. y Schaefer, E. J.: Apolipoprotein E alleles, dyslipidemia, and coronary heart disease. The Framingham Offspring Study. JAMA 1994; 272: 1666-1671.
  • World Health organization: (1994) The international clasification of diseases tenth edition, chapter five: Mental and behavioural disorders. 10th ed. Churchill Livingstone, London.
  • Ziehen, T.: (1911) Les demencies. In: Traite international psychologie pathologique. Vol. 2. (Ed: Marie, A.) Alcan, Paris, 281-381.
  • Zubenko, G. S., y Moosy, J.: (1988) Major depression in primary dementia: Clinical and neuropathological correlates. Arch. Neurol. 45: 1182-1186.